News and Announcements
The combination of a boosted protease inhibitor (lopinavir) with two nucleoside reverse-transcriptase inhibitors (NRTIs) is a feasible second-line therapy for HIV patients in Africa. These are the results of the EDCTP-funded EARNEST trial, coordinate...Read more » News, Announcements'
The interactive EDCTP Annual Report 2013 “The First Decade” is now available on the website. It gives access to the complete Annual Report 2013 in English, French and Portuguese, the Financial Statements for 2013, and an updated online overview of al...Read more » Announcements, Press Releases'
The core function of the European & Developing Countries Clinical Trials Partnership (EDCTP) is to fund clinical trials as a means to develop new or improved interventions regarding poverty-related and neglected infectious diseases in sub-Saharan Afr...Read more » Announcements, Press Releases'
Today, the Council of the European Union in its meeting on Economic and Financial Affairs (ECOFIN) has approved the participation of the European Union in the second programme of the European & Developing Countries Clinical Trials Partnership (EDCTP)...Read more »
Challenges in Malaria Research: Core science and innovation
22 September 2014
Third Global Symposium on Health Systems Research
30 September 2014
HIV Research for Prevention 2014 (HIV R4P)
28 October 2014
EDCTP Stakeholder meetings